Get startedLog in
    Picture of Bayer AG logo

    BAYN — Bayer AG Cashflow Statement

    0.000.00%
    de flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapTurnaround
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-15,5611,0224,166-2,942-2,546
    Depreciation
    Non-Cash Items1,1987955211,8981,562
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital6,000255-4,094-3,859-433
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Taxes Payable
    Other Operating Cash Flow
    Cash from Operating Activities4,8965,1287,0965,1177,366
    Capital Expenditures-2,418-2,611-2,949-2,751-2,778
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-1,6553,466568-7662,942
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-4,073855-2,381-3,517164
    Financing Cash Flow Items-1,276-1,200-1,251-1,552-2,013
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities423-5,645-4,220-679-7,178
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash1,006373607736284